Osseointegration of dental implants can be promoted by implant-surface modifications using bisphosphonate coatings. In addition, it is of clinical interest to promote peri-implant bone formation and to restore bony structure in low bone-mass patients. The present study evaluated a combination of an anti-resorptive zoledronic acid (ZOL) implant-coating and a systemically applied sclerostin antibody, a known bone anabolic treatment principle, versus sole sclerostin antibody treatment or ZOL implant-coating in a rat osteoporosis model.
Find out more
Join our next Thommen Talk Series Webinar about the “Socket Shield Technique” on July 9th (In German only).
Thursday, July 9th, 2020 at 18:00pm CEST - Socket Shield Technique: Can it work? Speaker: Dr. C. Andreoni and Dr. T. Meier.